Categories Earnings, Finance

Earnings Summary: A snapshot of FactSet’s Q2 2025 report

FactSet Research Systems Inc. (NYSE: FDS), a leading provider of data analytics services, on Thursday announced financial results for the second quarter of 2025.

  • FactSet’s second-quarter revenues increased 4.5% year-over-year to $570.7 million
  • Organic Annual Subscription Value was $2.28 billion in the February quarter, up 4.1% year over year
  • Q2 earnings, on a reported basis, rose 3% year-over-year to $3.76 per share; adjusted earnings per share moved up 1.4% to $4.28
  • Net income was $144.86 million in the February quarter, vs. $140.94 million in the prior-year quarter
  • At 32.5%, operating margin was down approximately 80 basis points year-over-year in Q2; adjusted operating margin dropped by 100 basis points to 37.3%
  • For fiscal 2025, the management expects organic Annual Subscription Value to grow between $100 million and $130 million, or 4.4% to 5.8%
  • Full-year revenue is expected to be in the range of $2.31 billion to $2.33 billion, and adjusted operating margin in the 36-37% range
  • Adjusted earnings per share are expected to be in the range of $16.80 to $17.40 in FY25

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Citigroup set to report Q4 2025 earnings. Here’s what to expect

Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the

Home Depot (HD), Lowe’s (LOW): Home improvement pressures not expected to abate soon

Home improvement retailers Home Depot (NYSE: HD) and Lowe’s Companies, Inc. (NYSE: LOW) have been facing a challenging operating environment for a while now. The companies have been battling macroeconomic

Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%

Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026. In Q2, net sales increased 8.8% year-over-year to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top